Patents by Inventor Shengguo Sun

Shengguo Sun has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11306067
    Abstract: Compounds or pharmaceutical acceptable salts thereof of Formula (I), in which RM have the meaning described herein and pharmaceutical compositions thereof useful as antimicrobial and/or adjuvant:
    Type: Grant
    Filed: March 1, 2019
    Date of Patent: April 19, 2022
    Assignee: Denovamed Inc.
    Inventors: Fan Wu, Erhu Lu, Shengguo Sun, Christopher J. Barden
  • Publication number: 20210017147
    Abstract: Compounds or pharmaceutical acceptable salts thereof of Formula (I), in which RM have the meaning described herein and pharmaceutical compositions thereof useful as antimicrobial and/or adjuvant:
    Type: Application
    Filed: March 1, 2019
    Publication date: January 21, 2021
    Applicant: Denovamed Inc.
    Inventors: Fan WU, Erhu LU, Shengguo SUN, Christopher J. BARDEN
  • Publication number: 20140357725
    Abstract: The present application provides terpene analogues of Formula 1 and methods and uses thereof for treating neurological conditions such as pain in general and neuropathic pain specifically. wherein: Y is a C1 to C20 alkylene, C?O, SO, SO2, or absent; X is H, OR1, N—(R2)2, a C1 to C20 alkyl, or a heterocyclyl (for example, heteroaryl), wherein when Y is absent X is not H; R1 is H, a C1 to C20 alkyl, or a CH2-aryl; R2 is independently H, a C1 to C20 alkyl, aryl, OR1, CN or C(?O)—R3; R3 is a substituted or unsubstituted C1 to C20 alkyl, or a aryl; W is H, C1 to C20 alkyl, or aryl; and Z is C1 to C20 alkylene; or a pharmaceutically acceptable isomer, salt or ester thereof. These terpene analogues are useful in treating pain and can also be used to treat other electrical disorders in the central and peripheral nervous system.
    Type: Application
    Filed: July 13, 2012
    Publication date: December 4, 2014
    Applicant: NEUROQUEST INC.
    Inventors: Donald F. Weaver, Mark Andrew Reed, Alexander McLellan, Shengguo Sun
  • Publication number: 20130267571
    Abstract: The present application provides a terpene analogue of Formula (I) or a pharmaceutically acceptable isomer, salt or ester thereof, and methods and uses thereof for treating neurological conditions such as pain in general and neuropathic pain. These terpene analogues can also be used to treat other electrical disorders in the central and peripheral nervous system. Also provided are methods of synthesizing the terpene analogues of Formula I.
    Type: Application
    Filed: September 14, 2011
    Publication date: October 10, 2013
    Applicant: NeuroQuest Inc.
    Inventors: Mark A. Reed, Donald Weaver, Shengguo Sun, Alexander McLellan, Erhu Lu
  • Patent number: 8420640
    Abstract: The present invention is directed to compounds that inhibit amyloid aggregation and methods of treatment therewith.
    Type: Grant
    Filed: August 28, 2009
    Date of Patent: April 16, 2013
    Assignee: Treventis Corporation
    Inventors: Christopher J. Barden, Michael D. Carter, Mark A. Reed, Donald F. Weaver, Arun Yadav, Shengguo Sun
  • Publication number: 20110218200
    Abstract: The present invention is directed to compounds that inhibit amyloid aggregation and methods of treatment there-with.
    Type: Application
    Filed: August 28, 2009
    Publication date: September 8, 2011
    Inventors: Christopher J. Barden, Michael D. Carter, Mark A. Reed, Donald F. Weaver, Arun Yadav, Shengguo Sun